Irvine, CA – According to filings with the U.S. Securities and Exchange Commission, Oncocyte Corporation is raising $17,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ronald Andrews played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Oncocyte Corporation

Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce overall cost of care.

To learn more about Oncocyte Corporation, visit http://www.oncocyte.com/

Contact:
Ronald Andrews, Chief Executive Officer
949-409-7600

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved